Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study

Related Experiment Video

Updated: May 5, 2026

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

11.4K

Katharina Paul1, Daniel Kretzschmar, Atilla Yilmaz

  • 1Department of Internal Medicine III, Division of Nephrology, Jena University Hospital Friedrich-Schiller University, Erlanger Allee 101, Jena, 07740 Germany. katharina.paul@med.uni-jena.de.

BMC Nephrology
|December 12, 2013
PubMed

Insights

Chronic kidney disease (CKD) significantly lowers circulating dendritic cell precursors (DCP), including myeloid (mDCP) and plasmacytoid (pDCP) types. This reduction suggests DCP may mediate cardiovascular disease risk in CKD patients.

Area of Science:

  • Immunology
  • Nephrology
  • Cardiology

Background:

  • Dendritic cells (DCs) are key antigen-presenting cells involved in immune surveillance.
  • Circulating dendritic cell precursors (DCP) are found in blood and their decreased levels correlate with atherosclerotic plaque burden.
  • Chronic kidney disease (CKD) is linked to systemic inflammation and elevated cardiovascular risk.

Purpose of the Study:

  • To investigate the impact of CKD on circulating DCP numbers.
  • To assess if CKD influences myeloid (mDCP) and plasmacytoid (pDCP) subsets.
  • To explore the association between DCP levels, CKD, and cardiovascular disease history.

Main Methods:

  • Flow cytometry was used to quantify mDCP, pDCP, and total DCP (tDCP).
  • The study included 245 patients with CKD stage 3 and 85 healthy coronary controls.
  • Data were also compared with a historical cohort of 130 patients with coronary artery disease (CAD).

Main Results:

  • CKD patients showed significant reductions in mDCP (-29%), pDCP (-43%), and tDCP (-38%) compared to controls (P < 0.001).
  • The decrease in DCP observed in CKD patients was comparable to or more pronounced than that in patients with established CAD.
  • These findings suggest DCP may play a role in potentiating cardiovascular risk associated with CKD.

Conclusions:

  • The substantial decrease in DCP in CKD patients suggests a potential role as mediators of cardiovascular disease.
  • DCP may serve as a link between CKD and increased cardiovascular risk.
  • Future prospective trials are needed to establish DCP as potential cardiovascular biomarkers in CKD.
Abstract

More Related Videos

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells09:05

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

Published on: August 7, 2017

8.6K
Culture of myeloid dendritic cells from bone marrow precursors06:39

Culture of myeloid dendritic cells from bone marrow precursors

Published on: July 25, 2008

22.3K

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K